An impact investor in the biomedical field is an individual or organization that invests capital into companies or projects that are focused on developing and commercializing innovative medical technologies and treatments. The goal of impact investing in the biomedical field is to support the development of new treatments and therapies that have the potential to improve human health, while also generating a financial return on investment. Impact investors in the biomedical field typically focus on investments in early-stage companies or projects that have the potential to have a significant impact on human health, such as companies developing new treatments for diseases with high unmet medical needs, or companies working on innovative medical technologies with the potential to revolutionize the way that healthcare is delivered. The focus of impact investing in the biomedical field is not just on financial returns, but also on creating positive social and environmental impact. For example, an impact investor in the biomedical field might invest in a company that is working on developing a new treatment for a neglected tropical disease, or a company that is working to make healthcare more accessible and affordable in low- and middle-income countries. Overall, impact investing in the biomedical field provides an important source of capital for early-stage companies and projects, and it helps to support the development of innovative treatments and therapies that have the potential to make a significant impact on human health.